N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes

被引:147
|
作者
Galvani, M
Ottani, F
Oltrona, L
Ardissino, D
Gensini, GF
Maggioni, AP
Mannucci, PM
Mininni, N
Prando, MD
Tubaro, M
Vernocchi, A
Vecchio, C
机构
[1] Fdn Cardiol Sacco, I-47100 Forli, Italy
[2] Osped GB Morgagni, Forli, Italy
[3] Osped Niguarda Ca Granda, Milan, Italy
[4] Osped Maggiore Parma, Parma, Italy
[5] Univ Florence, Florence, Italy
[6] ANMCO Res Ctr, Florence, Italy
[7] Osped Maggiore, IRCCS, Milan, Italy
[8] Univ Milan, Milan, Italy
[9] Osped Monaldi, Naples, Italy
[10] Osped Maggiore della Carita, Novara, Italy
[11] Osped S Filippo Neri, Rome, Italy
[12] Osped Galliera, Genoa, Italy
关键词
natriuretic peptides; myocardial infarction; prognosis;
D O I
10.1161/01.CIR.0000134480.06723.D8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-The prognostic value of natriuretic peptide elevations in patients with acute coronary syndromes (ACS) is still incompletely defined. We measured N-terminal pro-brain natriuretic peptide (NT-proBNP) on admission in patients with ACS and ECG evidence of myocardial ischemia. Methods and Results-The NT-proBNP was measured at a median time of 3 hours after symptom onset in 1756 patients. The outcome measure was death at 30 days, which occurred in 113 patients (6.4%). The median NT-proBNP level was 353 ng/L (107 to 1357 ng/L). Compared with the lowest quartile, patients in the second, third, and fourth quartiles had a relative risk of subsequent death of 2.94 (95% CI, 1.15 to 7.52), 5.32 (95% CI, 2.19 to 12.91), and 11.5 (95% CI, 4.90 to 26.87), respectively. The NT-proBNP was independently associated with death in a logistic regression model, which included clinical variables, ECG, and troponin T in patients either with ( OR of highest versus lowest quartile, 7.0; 95% CI, 1.9 to 25.6) or without (OR of highest versus lowest quartile, 4.1; 95% CI, 1.1 to 14.6) persistent ST-segment elevation. NT-proBNP was also an independent predictor of severe heart failure. Conclusions-The measurement of NT-proBNP on admission improves the early risk stratification of patients with ACS, suggesting the need for the development of targeted therapeutic strategies.
引用
收藏
页码:128 / 134
页数:7
相关论文
共 50 条
  • [1] N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes
    Galvani, M
    Ottani, F
    Murena, E
    Oltrona, L
    Maras, P
    Tubaro, M
    Maggioni, A
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 402A - 402A
  • [2] Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes
    Omland, T
    de Lemos, JA
    Morrow, DA
    Antman, EN
    Cannon, CP
    Hall, C
    Braunwald, E
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (04): : 463 - +
  • [3] Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Acute Ischemic Stroke
    Son, K. H.
    Lee, D. S.
    Ha, Y. S.
    Kim, M. K.
    Yoo, B. G.
    [J]. CEREBROVASCULAR DISEASES, 2015, 40 : 50 - 50
  • [4] The prognostic value of N-terminal pro-brain natriuretic peptide in non-ST elevation acute coronary syndromes: a meta-analysis
    Zeng, Xiaocong
    Li, Lang
    Su, Qiang
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2012, 50 (04) : 731 - 739
  • [5] Urinary N-terminal pro-brain natriuretic peptide: prognostic value in patients with acute chest pain
    Reynen, Stefanie
    Schlossbauer, Michael
    Hubauer, Ute
    Hupf, Julian
    Mohr, Arno
    Orso, Evelyn
    Zimmermann, Markus
    Luchner, Andreas
    Maier, Lars S.
    Wallner, Stefan
    Jungbauer, Carsten G.
    [J]. ESC HEART FAILURE, 2021, 8 (03): : 2293 - 2305
  • [6] Prognostic value of N-terminal pro-brain natriuretic peptide in outpatients with hypertrophic cardiomyopathy
    D'Amato, R.
    Tomberli, B.
    Servettini, E.
    Spoladore, R.
    Cecchi, F.
    Camici, P. G.
    Olivotto, I.
    [J]. EUROPEAN HEART JOURNAL, 2012, 33 : 196 - 196
  • [7] Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy
    D'Amato, Rossella
    Tomberli, Benedetta
    Castelli, Gabriele
    Spoladore, Roberto
    Girolami, Francesca
    Fornaro, Alessandra
    Caldini, Anna
    Torricelli, Francesca
    Camici, Paolo
    Gensini, Gian Franco
    Cecchi, Franco
    Olivotto, Iacopo
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2013, 112 (08): : 1190 - 1196
  • [8] N-terminal pro-brain natriuretic peptide and coronary artery disease
    Karthikeyan, V. J.
    Lip, G. Y. H.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (01) : 1 - 7
  • [9] N-terminal pro-brain natriuretic peptide and coronary artery stenosis
    Yildiz, A.
    Gur, M.
    Yilmaz, R.
    Demirbag, R.
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2007, 37 (07) : 596 - 596
  • [10] Predictive value of N-terminal pro-brain natriuretic peptide in sepsis
    Tang, Benjamin M. P.
    Huang, Stephen J.
    Seppelt, Ian
    McLean, Anthony S.
    [J]. CRITICAL CARE MEDICINE, 2007, 35 (10) : 2464 - 2464